Literature DB >> 29109113

Generation and Characterization of SULT4A1 Mutant Mouse Models.

Patrick L Garcia1, Mohammed I Hossain1, Shaida A Andrabi1, Charles N Falany2.   

Abstract

Sulfotransferase 4A1 (SULT4A1) belongs to the cytosolic sulfotransferase (SULT) superfamily of enzymes that catalyze sulfonation reactions with a variety of endogenous and exogenous substrates. Of the SULTs, SULT4A1 was shown to have the highest sequence homology between vertebrate species, yet no known function or enzymatic activity has been identified for this orphan SULT. To better understand SULT4A1 function in mammalian brain, two mutant SULT4A1 mouse strains were generated utilizing clustered regulatory interspaced short palindromic repeats (CRISPR)-content-addressable storage (Cas) 9 technology. The first strain possessed a 28-base pair (bp) deletion (Δ28) in exon 1 that resulted in a frameshift mutation with premature termination. The second strain possessed a 12-bp in-frame deletion (Δ12) immediately preceding an active site histidine111 common to the SULT family. Homozygous pups of both strains present with severe and progressive neurologic symptoms, including tremor, absence seizures, abnormal gait, ataxia, decreased weight gain compared with littermates, and death around postnatal days 21-25. SULT4A1 immunostaining was decreased in brains of heterozygous pups and not detectable in homozygous pups of both SULT4A1 mutants. SULT4A1 localization in subcellular fractions of mouse brain showed SULT4A1 associated with mitochondrial, cytosolic, and microsomal fractions, a novel localization pattern for SULTs. Finally, primary cortical neurons derived from embryonic (E15) CD-1 mice expressed high levels of SULT4A1 throughout the cell except in nuclei. Taken together, SULT4A1 appears to be an essential neuronal protein required for normal brain function, at least in mammals. Mouse models will be valuable in future studies to investigate the regulation and functions of SULT4A1 in the mammalian brain.
Copyright © 2017 by The American Society for Pharmacology and Experimental Therapeutics.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29109113      PMCID: PMC5733458          DOI: 10.1124/dmd.117.077560

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  18 in total

1.  Transmission disequilibrium suggests a role for the sulfotransferase-4A1 gene in schizophrenia.

Authors:  Mark D Brennan; Jodi Condra
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2005-11-05       Impact factor: 3.568

2.  Regulation of mouse brain-selective sulfotransferase sult4a1 by cAMP response element-binding protein and activating transcription factor-2.

Authors:  Neville J Butcher; Deanne J Mitchell; Rachel Burow; Rodney F Minchin
Journal:  Mol Pharmacol       Date:  2010-06-22       Impact factor: 4.436

3.  Clinical and genomic evaluation of 201 patients with Phelan-McDermid syndrome.

Authors:  Sara M Sarasua; Luigi Boccuto; Julia L Sharp; Alka Dwivedi; Chin-Fu Chen; Jonathan D Rollins; R Curtis Rogers; Katy Phelan; Barbara R DuPont
Journal:  Hum Genet       Date:  2014-01-31       Impact factor: 4.132

4.  Inhibition of SULT4A1 expression induces up-regulation of phototransduction gene expression in 72-hour postfertilization zebrafish larvae.

Authors:  Frank Crittenden; Holly Thomas; Cheryl M Ethen; Zhengliang L Wu; Dongquan Chen; Timothy W Kraft; John M Parant; Charles N Falany
Journal:  Drug Metab Dispos       Date:  2014-02-19       Impact factor: 3.922

5.  Association of Sult4A1 SNPs with psychopathology and cognition in patients with schizophrenia or schizoaffective disorder.

Authors:  Herbert Y Meltzer; Mark D Brennan; Neil D Woodward; Karu Jayathilake
Journal:  Schizophr Res       Date:  2008-09-27       Impact factor: 4.939

6.  Cytosolic Aryl sulfotransferase 4A1 interacts with the peptidyl prolyl cis-trans isomerase Pin1.

Authors:  Deanne J Mitchell; Rodney F Minchin
Journal:  Mol Pharmacol       Date:  2009-05-13       Impact factor: 4.436

Review 7.  The neurobiology of epilepsy.

Authors:  Helen E Scharfman
Journal:  Curr Neurol Neurosci Rep       Date:  2007-07       Impact factor: 5.081

8.  Expression of the orphan cytosolic sulfotransferase SULT4A1 and its major splice variant in human tissues and cells: dimerization, degradation and polyubiquitination.

Authors:  Neelima P Sidharthan; Neville J Butcher; Deanne J Mitchell; Rodney F Minchin
Journal:  PLoS One       Date:  2014-07-02       Impact factor: 3.240

9.  Interstitial 22q13 deletions not involving SHANK3 gene: a new contiguous gene syndrome.

Authors:  Vittoria Disciglio; Caterina Lo Rizzo; Maria Antonietta Mencarelli; Mafalda Mucciolo; Annabella Marozza; Chiara Di Marco; Antonio Massarelli; Valentina Canocchi; Margherita Baldassarri; Enea Ndoni; Elisa Frullanti; Sonia Amabile; Britt Marie Anderlid; Kay Metcalfe; Cédric Le Caignec; Albert David; Alan Fryer; Odile Boute; Andrieux Joris; Donatella Greco; Vanna Pecile; Roberta Battini; Antonio Novelli; Marco Fichera; Corrado Romano; Francesca Mari; Alessandra Renieri
Journal:  Am J Med Genet A       Date:  2014-04-03       Impact factor: 2.802

10.  Structural and chemical profiling of the human cytosolic sulfotransferases.

Authors:  Abdellah Allali-Hassani; Patricia W Pan; Ludmila Dombrovski; Rafael Najmanovich; Wolfram Tempel; Aiping Dong; Peter Loppnau; Fernando Martin; Janet Thornton; Janet Thonton; Aled M Edwards; Alexey Bochkarev; Alexander N Plotnikov; Masoud Vedadi; Cheryl H Arrowsmith
Journal:  PLoS Biol       Date:  2007-05       Impact factor: 8.029

View more
  9 in total

1.  Sulfotransferase 4A1 Increases Its Expression in Mouse Neurons as They Mature.

Authors:  Takuyu Hashiguchi; Sawako Shindo; Shih-Heng Chen; Jau-Shyong Hong; Masahiko Negishi
Journal:  Drug Metab Dispos       Date:  2018-04-06       Impact factor: 3.922

Review 2.  Sulfation pathways from red to green.

Authors:  Süleyman Günal; Rebecca Hardman; Stanislav Kopriva; Jonathan Wolf Mueller
Journal:  J Biol Chem       Date:  2019-07-02       Impact factor: 5.157

3.  SULT4A1 Protects Against Oxidative-Stress Induced Mitochondrial Dysfunction in Neuronal Cells.

Authors:  Mohammed I Hossain; Joshua M Marcus; Jun Hee Lee; Patrick L Garcia; Jean-Philippe Gagné; Guy G Poirier; Charles N Falany; Shaida A Andrabi
Journal:  Drug Metab Dispos       Date:  2019-07-02       Impact factor: 3.922

4.  SULT4A1 Modulates Synaptic Development and Function by Promoting the Formation of PSD-95/NMDAR Complex.

Authors:  Lorenza Culotta; Paolo Scalmani; Ersilia Vinci; Benedetta Terragni; Alessandro Sessa; Vania Broccoli; Massimo Mantegazza; Tobias Boeckers; Chiara Verpelli
Journal:  J Neurosci       Date:  2020-08-12       Impact factor: 6.167

Review 5.  SULT genetic polymorphisms: physiological, pharmacological and clinical implications.

Authors:  Katsuhisa Kurogi; Mohammed I Rasool; Fatemah A Alherz; Amal A El Daibani; Ahsan F Bairam; Maryam S Abunnaja; Shin Yasuda; Lauren J Wilson; Ying Hui; Ming-Cheh Liu
Journal:  Expert Opin Drug Metab Toxicol       Date:  2021-06-30       Impact factor: 4.936

Review 6.  Animal Models of Tremor: Relevance to Human Tremor Disorders.

Authors:  Ming-Kai Pan; Chun-Lun Ni; Yeuh-Chi Wu; Yong-Shi Li; Sheng-Han Kuo
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2018-10-09

Review 7.  Genotype-phenotype correlation in Phelan-McDermid syndrome: A comprehensive review of chromosome 22q13 deleted genes.

Authors:  Arianna Ricciardello; Pasquale Tomaiuolo; Antonio M Persico
Journal:  Am J Med Genet A       Date:  2021-05-05       Impact factor: 2.802

8.  Phenotypic Variability in Phelan-McDermid Syndrome and Its Putative Link to Environmental Factors.

Authors:  Luigi Boccuto; Andrew Mitz; Ludovico Abenavoli; Sara M Sarasua; William Bennett; Curtis Rogers; Barbara DuPont; Katy Phelan
Journal:  Genes (Basel)       Date:  2022-03-17       Impact factor: 4.096

9.  Sulfotransferase 4A1 activity facilitates sulfate-dependent cellular protection to oxidative stress.

Authors:  Evan J Brettrager; Arthur W Meehan; Charles N Falany; Robert C A M van Waardenburg
Journal:  Sci Rep       Date:  2022-01-31       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.